AACN CCNS (NEONATAL)
Final Test Review
2025
1. Which of the following is a common cause of patent ductus
arteriosus (PDA) in neonates?
- A) Genetic mutation
- B) Premature birth
- C) Maternal diabetes
- D) Fetal alcohol syndrome
- ANS: B) Premature birth
- Rationale: Premature birth is a common cause of patent
ductus arteriosus (PDA) as the ductus arteriosus often fails to
close after birth in preterm infants.
Fill-in-the-Blank Questions
©2025
,2. The __________ is a non-invasive method used to monitor
oxygen saturation levels in neonates.
- ANS: pulse oximeter
- Rationale: A pulse oximeter is used to non-invasively
monitor oxygen saturation levels in neonates.
True/False Questions
3. True or False: Bradycardia in neonates can be a sign of
hypoxia.
- ANS: True
- Rationale: Bradycardia can be a sign of hypoxia in
neonates, indicating inadequate oxygenation.
Multiple Response Questions
4. Which of the following are signs of congestive heart failure
(CHF) in neonates? (Select all that apply)
- A) Tachycardia
- B) Poor feeding
- C) Weight gain
- D) Cyanosis
- ANS: A) Tachycardia, B) Poor feeding, D) Cyanosis
©2025
, - Rationale: Signs of congestive heart failure in neonates
include tachycardia, poor feeding, and cyanosis. Weight gain is
not typically a sign of CHF in neonates.
Pulmonary System
Multiple Choice Questions
5. What is the primary purpose of administering surfactant
therapy to preterm neonates?
- A) To reduce respiratory rate
- B) To increase oxygen consumption
- C) To improve lung compliance and reduce respiratory distress
- D) To decrease heart rate
- ANS: C) To improve lung compliance and reduce respiratory
distress
- Rationale: Surfactant therapy helps improve lung
compliance and reduce respiratory distress in preterm neonates by
reducing surface tension in the alveoli.
Fill-in-the-Blank Questions
6. __________ is a common respiratory condition in preterm
neonates characterized by the incomplete development of the
lungs.
©2025
, - ANS: Respiratory distress syndrome (RDS)
- Rationale: Respiratory distress syndrome (RDS) is a
common condition in preterm neonates caused by the incomplete
development of the lungs.
True/False Questions
7. True or False: Apnea of prematurity is a condition where
preterm neonates experience pauses in breathing for more than 20
seconds.
- ANS: True
- Rationale: Apnea of prematurity involves pauses in
breathing for more than 20 seconds, often seen in preterm
neonates.
Multiple Response Questions
8. Which of the following interventions are used to manage
bronchopulmonary dysplasia (BPD) in neonates? (Select all that
apply)
- A) Oxygen therapy
- B) Mechanical ventilation
- C) Diuretics
- D) Antibiotics
- ANS: A) Oxygen therapy, B) Mechanical ventilation, C)
Diuretics
©2025
Final Test Review
2025
1. Which of the following is a common cause of patent ductus
arteriosus (PDA) in neonates?
- A) Genetic mutation
- B) Premature birth
- C) Maternal diabetes
- D) Fetal alcohol syndrome
- ANS: B) Premature birth
- Rationale: Premature birth is a common cause of patent
ductus arteriosus (PDA) as the ductus arteriosus often fails to
close after birth in preterm infants.
Fill-in-the-Blank Questions
©2025
,2. The __________ is a non-invasive method used to monitor
oxygen saturation levels in neonates.
- ANS: pulse oximeter
- Rationale: A pulse oximeter is used to non-invasively
monitor oxygen saturation levels in neonates.
True/False Questions
3. True or False: Bradycardia in neonates can be a sign of
hypoxia.
- ANS: True
- Rationale: Bradycardia can be a sign of hypoxia in
neonates, indicating inadequate oxygenation.
Multiple Response Questions
4. Which of the following are signs of congestive heart failure
(CHF) in neonates? (Select all that apply)
- A) Tachycardia
- B) Poor feeding
- C) Weight gain
- D) Cyanosis
- ANS: A) Tachycardia, B) Poor feeding, D) Cyanosis
©2025
, - Rationale: Signs of congestive heart failure in neonates
include tachycardia, poor feeding, and cyanosis. Weight gain is
not typically a sign of CHF in neonates.
Pulmonary System
Multiple Choice Questions
5. What is the primary purpose of administering surfactant
therapy to preterm neonates?
- A) To reduce respiratory rate
- B) To increase oxygen consumption
- C) To improve lung compliance and reduce respiratory distress
- D) To decrease heart rate
- ANS: C) To improve lung compliance and reduce respiratory
distress
- Rationale: Surfactant therapy helps improve lung
compliance and reduce respiratory distress in preterm neonates by
reducing surface tension in the alveoli.
Fill-in-the-Blank Questions
6. __________ is a common respiratory condition in preterm
neonates characterized by the incomplete development of the
lungs.
©2025
, - ANS: Respiratory distress syndrome (RDS)
- Rationale: Respiratory distress syndrome (RDS) is a
common condition in preterm neonates caused by the incomplete
development of the lungs.
True/False Questions
7. True or False: Apnea of prematurity is a condition where
preterm neonates experience pauses in breathing for more than 20
seconds.
- ANS: True
- Rationale: Apnea of prematurity involves pauses in
breathing for more than 20 seconds, often seen in preterm
neonates.
Multiple Response Questions
8. Which of the following interventions are used to manage
bronchopulmonary dysplasia (BPD) in neonates? (Select all that
apply)
- A) Oxygen therapy
- B) Mechanical ventilation
- C) Diuretics
- D) Antibiotics
- ANS: A) Oxygen therapy, B) Mechanical ventilation, C)
Diuretics
©2025
